These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34913594)

  • 1. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Lu Y; Liu S; Li Y; Chen S
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TOX expression associates with exhausted T cells in patients with multiple myeloma.
    Zhao Y; Liao P; Huang S; Deng T; Tan J; Huang Y; Zhan H; Li Y; Chen S; Zhong L
    Exp Hematol Oncol; 2022 Mar; 11(1):12. PubMed ID: 35246241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemia.
    Tan J; Huang S; Huang J; Yu Z; Chen Y; Lu Y; Li Y; Chen S
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):137-141. PubMed ID: 32030888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML.
    Tan J; Yu Z; Huang J; Chen Y; Huang S; Yao D; Xu L; Lu Y; Chen S; Li Y
    Biomark Res; 2020; 8():6. PubMed ID: 32082573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with
    Tan J; Chen S; Lu Y; Yao D; Xu L; Zhang Y; Yang L; Chen J; Lai J; Yu Z; Zhu K; Li Y
    Chin J Cancer Res; 2017 Oct; 29(5):463-470. PubMed ID: 29142466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
    Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S
    Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of TIGIT
    Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
    Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
    Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
    Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and Significance of PD-1, TIM-3 and VISTA on T Cell of Acute Myeloid Leukemia Patients].
    Ge MJ; Xu KL; Xu T; Tang YN; Li ZY; Yan ZL; Sun HY; Cheng H; Zhu F; Sang W; Huang YH; Qiu TT; Li DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):748-752. PubMed ID: 32552931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
    Dama P; Tang M; Fulton N; Kline J; Liu H
    J Immunother Cancer; 2019 Jul; 7(1):175. PubMed ID: 31291985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma.
    Huang S; Zhao Y; Liao P; Wang J; Li Z; Tan J; Zha X; Chen S; Li Y; Zhong L
    Front Oncol; 2022; 12():1014904. PubMed ID: 36439426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher frequency of the CTLA-4
    Chen Y; Tan J; Huang S; Huang X; Huang J; Chen J; Yu Z; Lu Y; Weng J; Du X; Li Y; Zha X; Chen S
    Asia Pac J Clin Oncol; 2020 Apr; 16(2):e12-e18. PubMed ID: 31612643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.
    Zhou Q; Munger ME; Veenstra RG; Weigel BJ; Hirashima M; Munn DH; Murphy WJ; Azuma M; Anderson AC; Kuchroo VK; Blazar BR
    Blood; 2011 Apr; 117(17):4501-10. PubMed ID: 21385853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Corradi G; Forte D; Cristiano G; Polimeno A; Ciciarello M; Salvestrini V; Bandini L; Robustelli V; Ottaviani E; Cavo M; Ocadlikova D; Curti A
    Front Immunol; 2024; 15():1386517. PubMed ID: 38812504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
    Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
    Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.